Literature DB >> 22722397

Stem cells. Antipsychotic to anticancer agent?

Darren J Burgess.   

Abstract

A new study shows that a clinically approved drug might selectively target cancer stem cells for differentiation.

Entities:  

Year:  2012        PMID： 22722397     DOI： 10.1038/nrc3305

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  1 in total

1.  Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.

Authors:  Eleftherios Sachlos; Ruth M Risueño; Sarah Laronde; Zoya Shapovalova; Jong-Hee Lee; Jennifer Russell; Monika Malig; Jamie D McNicol; Aline Fiebig-Comyn; Monica Graham; Marilyne Levadoux-Martin; Jung Bok Lee; Andrew O Giacomelli; John A Hassell; Daniela Fischer-Russell; Michael R Trus; Ronan Foley; Brian Leber; Anargyros Xenocostas; Eric D Brown; Tony J Collins; Mickie Bhatia
Journal:  Cell       Date:  2012-05-24       Impact factor: 41.582
  1 in total
  2 in total

1.  DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information.

Authors:  I Amelio; M Gostev; R A Knight; A E Willis; G Melino; A V Antonov
Journal:  Cell Death Dis       Date:  2014-02-06       Impact factor: 8.469

2.  [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].

Authors:  Juan Li; Yi Wang; Liu Liu; Yuan Yuan; Yangyi Bao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.